Crucell NV, of Leiden, the Netherlands, appointed Stef Heylen vice president, development and regulatory affairs.

CV Therapeutics Inc., of Palo Alto, Calif., appointed Kenneth Lee to its board.

Cyanotech Corp., of Kailua-Kona, Hawaii, named Bob Capelli director of sales.

Diversys Ltd., of Cambridge, UK, added Kevin Moulder as vice president of research and development.

Enchira Biotechnology Corp., of The Woodlands, Texas, added John Smyth, James Swartz and Adrian Lee to its scientific advisory board.

Genzyme Molecular Oncology, a division of Genzyme Corp., of Cambridge, Mass., appointed Beverly Teicher as a cancer research scientist for its anti-angiogenesis program.

Incyte Genomics Inc., of Palo Alto, Calif., appointed Richard De Schutter and Paul Brooke to its board.

Kos Pharmaceuticals Inc., of Miami, appointed Richard King senior vice president of commercial operations.

Medinox Inc., of San Diego, appointed Carolyn Rynard vice president of product development.

Nabi, of Boca Raton, Fla., added Stephen Sudovar to its board.

Northwest Biotherapeutics Inc., of Bothell, Wash., added Jim Johnston as executive vice president, chief financial officer and chief general counsel.

Novirio Pharmaceuticals Inc., of Cambridge, Mass., appointed George Chao vice president, biostatistics and data management.

Panacos Pharmaceuticals Inc., of Gaithersburg, Md., appointed David Martin vice president, drug development.

PPD Inc., of Wilmington, N.C., named Fred Davenport president and promoted Paul Covington to executive vice president of development.

Quintiles Transnational Corp., of Research Triangle Park, N.C., appointed Tracy Tsuetaki senior vice president, global business development.

RxKinetix Inc., of Louisville, Colo., named John Carpenter, Mark Manning and Ted Randolph to its scientific advisory board.

Scion Pharmaceuticals Inc., of Medford, Mass., appointed Robert Zelle vice president of chemistry, Phillip Friden vice president of biology and Aninda Katragadda vice president of finance and administration.

Scion Pharmaceuticals Inc., of Medford, Mass., appointed Robert Zelle vice president of chemistry, Phillip Friden vice president of biology and Aninda Katragadda vice president of finance and administration.

The Automation Partnership, of Cambridge, UK, added Rod Westrop as genomics business manger.

Varian Inc., of Palo Alto, Calif., promoted Martin O’Donoghue to vice president and general manager of chromatography and analytical supplies.

ViaCell Inc., of Boston, added Robert Silverman as senior vice president, commercial operations; appointed Donald Brown senior director of marketing for Viacord; and named David Blackett director of marketing.

Xpogen Inc., of Cambridge, Mass., named Michael Fahy vice president of sales and Robert Halpern vice president of business development.